Haleon PLC HLN-GB:London Stock Exchange

RT Quote | Exchange | GBp
Last | 05/10/24 BST
327.80quote price arrow down-0.20 (-0.06%)
52 week range
306.80 - 350.50
Loading...
  • Open327.20
  • Day High328.00
  • Day Low326.20
  • Prev Close328.00
  • 52 Week High350.50
  • 52 Week High Date05/12/23
  • 52 Week Low306.80
  • 52 Week Low Date07/07/23

Key Stats

  • Market Cap37,848.53M
  • Shares Out9,132.3M
  • 10 Day Average Volume21.68M
  • Dividend6.00
  • Dividend Yield1.83%
  • Beta-
  • YTD % Change1.91

KEY STATS

  • Open327.20
  • Day High328.00
  • Day Low326.20
  • Prev Close328.00
  • 52 Week High350.50
  • 52 Week High Date05/12/23
  • 52 Week Low306.80
  • 52 Week Low Date07/07/23
  • Market Cap37,848.53M
  • Shares Out9,132.3M
  • 10 Day Average Volume21.68M
  • Dividend6.00
  • Dividend Yield1.83%
  • Beta-
  • YTD % Change1.91

RATIOS/PROFITABILITY

  • EPS (TTM)11.81
  • P/E (TTM)27.76
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date03/14/2024
  • Div Amount4.20
  • Split Date-
  • Split Factor-

Latest On Haleon PLC

 

Profile

MORE
Haleon plc is a consumer healthcare company. The Company's product portfolio includes five categories, including oral health, vitamins, minerals, and supplements (VMS), pain relief, respiratory health, digestive health and others. The Company’s geographical segments include North America, Europe, Middle East, Africa, and Latin America (EMEA and LatAm, and Asia Pacific (APAC). Its respiratory health brands offer product solutions for a range of respiratory issues, including...
Dave Lewis
Independent Non-Executive Chairman of the Board
Brian Mcnamara
Chief Executive Officer, Executive Director
Tobias Hestler
Chief Financial Officer, Executive Director
Bjarne Tellmann
General Counsel
Address
Building 5, First Floor, The Heights
Weybridge
KT13 0NY
United Kingdom